INTRODUCTION
In contrast to the effector CD4 + T helper 1 (Th1) and Th2 cells that produce interferon-g (IFN-g) and interleukin 4 (IL-4), respectively, Th17 cells uniquely produce two related effector cytokines, IL-17 and IL-17F, and these cytokines have been shown to be important in immunity against bacteria and fungi (Korn et al., 2009 ). However, because of the powerful proinflammatory activities conferred by IL-17 and IL-17F, Th17 cells also potently induce or maintain tissue inflammation and can cause many inflammatory and autoimmune diseases, including multiple sclerosis (MS), asthma, rheumatoid arthritis (RA), and inflammatory bowl diseases (IBD) (Dong, 2008; Korn et al., 2009) . Therefore, the transcriptional regulation of the Il17 and Il17f genes has attracted much attention recently.
The Il17 and Il17f genes are encoded at the same chromosomal locus. They are separated by $43.9 kb in mice and are transcribed in opposite directions. Th17 cell differentiation requires IL-6 and transforming growth factor (TGF)-b (Dong, 2008; Korn et al., 2009) , and IL-1 is also important in regulating early Th17 cell differentiation (Chung et al., 2009 ). These cytokines, together with T cell receptor signaling, lead to activation of signal transducer and activator of transcription 3 (STAT3), interferon regulatory factor 4 (IRF4), retinoic acid-related orphan receptor (ROR)gt, RORa, Runt-related transcription factor 1 (RUNX1), B cell-activating transcription factor (Batf), and IkappaBz (IkBz) (Chen et al., 2006; Ivanov et al., 2006; Okamoto et al., 2010; Schraml et al., 2009; Yang et al., 2008b; Zhang et al., 2008) . Among these transacting factors, RORgt is identified as the ''master regulator'' in Th17 cells and is both necessary and sufficient for IL-17 and IL-17F expression (Ivanov et al., 2006) . RORa plays redundant and synergistic functions with RORgt (Yang et al., 2008b) . Despite these studies on trans-acting factors, their target cis-acting elements in driving selective Th17-specific cytokine expression are poorly understood.
cis-acting regulatory elements are often conserved across species (Meireles-Filho and Stark, 2009 ) and have been shown to be crucial in controlling T cell differentiation. In Th2 cells, the effector cytokine genes are controlled by a conserved noncoding sequence (CNS) 1 located between the Il4 and Il13 genes, a locus control region (LCR) between the Il13 and Il5 genes, an intronic enhancer HS2 within the Il4 gene, and several other cis elements (Lee et al., 2001; Solymar et al., 2002; Tanaka et al., 2011) . Targeted deletion of these cis elements impairs the expression of Th2 cytokines in vitro and in vivo (Loots et al., 2000; Lee et al., 2005; Tanaka et al., 2011) . In regulatory T (Treg) cells, the stability, frequency, and tissue-or organ-specific development of forkhead box P3 (FOXP3 + ) T cells are controlled by three different noncoding sequences, CNS1-CNS3 (Zheng et al., 2010) . The expression of IFN-g in Th1 cells may be controlled predominantly by a T-bet-dependent enhancer CNS22, a conserved sequence located 22 kb upstream of the Ifng gene, based on studies with a transgenic model (Hatton et al., 2006) . In T cell development, one important feature of cis-acting regulatory elements is that they undergo permissive chromatin remodeling in a lineage-specific manner, thereby allowing the binding of various trans-acting factors for selective gene transcription. Additionally, the distal cis-regulatory elements may interact with the cytokine gene promoters by forming a three-dimentional loop, which therefore provides a platform capable of initiating gene transcription by bringing together trans-acting factors to a close spatial proximity, such as the cis-regulatory loop formed at the Th2 cytokine gene locus (Spilianakis and Flavell, 2004) .
To characterize the mechanism underlying lineage-specific expression of IL-17 and IL-17F, we previously identified a total of eight conserved noncoding sites (CNS) in the Il17-Il17f locus by sequence comparison and found at least several of them, including CNS2, were associated with hyperacetylated histone H3, a marker of permissive chromatin structure (Wilson et al., 2009) , in Th17 cells (Akimzhanov et al., 2007) . The lineagespecific chromatin remodeling of CNS2 and the Il17-Il17f locus was recently confirmed by global mapping histone modifications in different T helper cells (Wei et al., 2009) . Interestingly, we observed that CNS2 functioned to promote the activation of Il17 gene promoter possibly through binding to ROR factors (Yang et al., 2008b) . In addition, CNS2 may also interact with other Th17 cell-regulating transcription factors (Okamoto et al., 2010; Schraml et al., 2009; Zhang et al., 2008) . These in vitro data together suggest that CNS2 may be important in regulating IL-17 expression in vivo. In this study, we generated CNS2-deficient mice by homologous recombination. With these mice, the role of CNS2 and the underlying mechanism in regulating IL-17 and IL-17F expression and Th17 cell differentiation was evaluated in both in vitro and in vivo systems.
RESULTS

CNS2
Regulated the Lineage-Specific Transcription of Both Il17 and Il17f Genes To test whether CNS2 functions as a lineage-specific regulatory element, we first assessed whether it was bound by p300, because p300 binding has recently shown to predict enhancer elements in the genome (Visel et al., 2009 ). We therefore performed a chromatin immunoprecipitation (ChIP) assay with an antibody to p300. CNS2 was bound by p300 specifically in Th17 but not in Th1 cells whereas the Ifng promoter (IFN-gp) interacted with p300 only in Th1 cells ( Figure S1A available online).
The regulation of IL-17 by CNS2 has been suggested by luciferase reporter assays in EL4 and Jurkat cells (Yang et al., 2008b; Zhang et al., 2008) . To further test whether CNS2 dictates Th17 cell-specific transcription of the Il17 and Il17f genes, we developed a luciferase reporter assay in primary T cells. Whereas the Il17 or Il17f gene promoter did not exhibit substantially increased activation in Th17 compared to Th1 cells, addition of CNS2 increased the Il17 promoter activity by approximately 9.5-fold in Th17 but not Th1 cells ( Figure 1A ). In addition, CNS2 also increased the cell type-specific Il17f promoter activity ( Figure 1A ). These results suggest that CNS2 is sufficient in driving lineage-specific transcription of the Il17 and Il17f genes. To examine whether the role of CNS2 is dependent on binding by ROR factors, the two ROR-binding sites (RORE) predicted in the CNS2 region were mutated, which consistently led to $50% reduction of the promoter activity of the CNS2-Il17 reporter construct ( Figure 1A ), although it completely lost ROR-mediated transcription in EL4 cells (Figure S1B) , excluding the presence of additional RORE sites in the CNS2 region.
Interestingly, we found that CNS2, when fused to the Ifng or Il4 promoters, robustly induced their transcription in Th17 cells, and even in EL4 or 293T cells (Figures S1C-S1E), indicating that CNS2 can function independent of Il17 or Il17f gene promoter to regulate Th17 cell-specific transcription. Taken together, these results suggest that CNS2 is sufficient in mediating lineage-specific transcription of Il17 and Il17f genes, possibly by serving as an enhancer element.
Interacted with Both the Il17 and Il17f Promoters in Th17 Cells CNS2 is located $2 kb upstream of the Il17 gene promoter and $56.5 kb away from the Il17f gene in mice (Akimzhanov et al., 2007) . To investigate the mechanism underlying this longdistance regulation, we performed a chromosome conformation capture (3C) assay-a powerful technology that can detect longrange intra-or interchromosomal associations between distantly related DNA elements (Tolhuis et al., 2002) . In this technique, DNA-protein complexes are covalently crosslinked by formaldehyde or paraformaldehyde. After restriction enzyme digestion, DNA fragments crosslinked together in the same complex can be preferentially ligated together when diluted to a very low concentration, which can be detected by PCR amplification. In Th17 but not Th1 cells, we found that the 5 0 -end of CNS2 can be directly ligated to the 3 0 -end of Il17p based on the size of PCR product ( Figure 1B ). Moreover, a strong association of CNS2 with the Il17fp was also observed ( Figure 1B) . The cell type-specific association with the Il17 and Il17f promoters further suggests an important role of CNS2 in regulating lineagespecific Il17 and Il17f gene transcription.
CNS2 Was Required for IL-17 and Optimal IL-17F Expression in Th17 Cells Generated In Vitro
The importance of CNS2 in the control of IL-17 and IL-17F gene expression has thus far been highlighted by luciferase reporter assays and 3C analysis. To further test the function of CNS2 genetically, CNS2-deficient mice were generated by homologous recombination and the neomycin-selecting gene was subsequently removed by loxp-cre system to avoid its influence over transcription of endogenous genes ( Figure S2A ). The deletion of CNS2 in mice was confirmed by PCR ( Figure S2B ). Naive CD4 + T cells were isolated from both the CNS2 wildtype (WT) and CNS2-deficient mice and polarized into various effector Th cells. The gene expression pattern of these effector T cells was then analyzed by different assays including intracellular staining, real-time RT-PCR, and ELISA (enzyme-linked immunosorbent assay). CNS2-deficient T cells expressed less than 10% IL-17 and less than 30%-55% IL-17F compared with the WT cells under different Th17 cell conditions (Figures 2, S2C, and S2D), although they displayed normal Th1, Th2, and iTreg cell differentiation ( Figure S2E ). The expression of other Th17 cell-related genes, including ROR factors and IL-21, was not affected in CNS2-deficient cells ( Figure S2C ). These data indicate that CNS2 functions downstream of RORs in mediating the Il17 and Il17f gene transcription. To ascertain this, ROR factors were retrovirally overexpressed in both WT and CNS2-deficient T cells cultured under Th0 and Th17 cell conditions. Remarkably, overexpression of ROR factors even under Th17 cell-polarized condition could not lead to any noticeable expression of IL-17 in CNS2-deficient cells (Figures 3A and 3B) . In addition, a strong reduction in IL-17F expression was also observed in CNS2-deficient cells (Figures 3A and 3B) . This result suggests that CNS2 is required for the function of ROR factors in mediating IL-17 expression in Th17 cells. S2C , and S2D), deletion of CNS2 greatly reduced the binding of RNA Pol II to the Il17 promoter whereas the binding to the Il17f promoter was only partially affected ( Figure 4A ). To assess whether the chromatin accessibility at the Il17-Il17f gene locus may be altered by the absence of CNS2, a ChIP assay was performed with antibodies against acetyl histone H3 (H3Ac) and K27-trimethylated histone (H3K27me3) in Th17 cells. In the Il17 promoter region, permissive histone marker H3Ac was significantly reduced in CNS2-deficient cells along with increased presence of repressive histone marker H3K27me3 ( Figure 4B ; Wilson et al., 2009 ). In addition, chromatin remodeling was also affected, though to a lesser extent, in the Il17f promoter region and other CNS sites ( Figure 4B ). The results here thus suggest that chromatin remodeling of the Il17-Il17f locus is at least partially dependent on CNS2. Moreover, the extent of the altered chromatin structures caused by CNS2 deficiency at the respective promoter regions was consistent with the level of cytokine expression.
CNS2 Controlled Chromatin
To further understand how CNS2 regulates chromatin accessibility, we examined the binding of several histone remodeling enzymes to CNS2 and to the Il17-Il17f promoter regions and found that CNS2 interacted with p300 and JmjC domain-containing protein 3 (JMJD3) in Th17 cells ( Figure 4C ). p300 contains histone acetyltransferases (HAT) activity and mediates permissive histone acetylation (Wang et al., 2008) ; JMJD3 has been identified as a histone demethylase that specifically removes repressive histone marker H3K27me3 (Agger et al., 2007; De Santa et al., 2007; Xiang et al., 2007) . Considering CNS2 association with both the Il17 and Il17f promoters as shown by our 3C analysis, binding of these histone remodeling enzymes to CNS2 may increase their localization near the promoters and therefore increase locus-specific enzymatic activity. Interestingly, deletion of CNS2 significantly decreased the binding of p300 to the Il17 promoter but less to the Il17f promoter in Th17 cells ( Figure 4C ).
Previous ChIP and electrophoretic mobility shift (EMS) assays suggest that RORgt physically interacted with CNS2 (Yang et al., 2008b; Zhang et al., 2008) . In our retroviral overexpression assays, we found that CNS2 was functionally required for ROR-dependent IL-17 expression in Th17 cells (Figure 3 ). To further understand the mechanism underlying CNS2-dependent IL-17 transcription, we investigated the role of RORg in chromatin activation of the Il17-Il17f gene locus. We found that the Il17 promoter showed a hallmark of ''closed'' chromatin structure in RORg-deficient Th17 cells characterized by greatly reduced H3Ac and increased H3K27me3 ( Figure S3 ). However, the Il17fp region was only mildly affected by the deletion of RORg ( Figure S3 ). The RORgt-deficient Th17 cells thus displayed a similar, although not identical, phonotype to that of CNS2-deficient Th17 cells (Figures 4B and S3) .
Our results altogether support a model that RORgt (and RORa) binds to CNS2 and initiates chromatin remodeling at Il17-Il17f locus, in which CNS2 provides a necessary binding site for RORgt to activate the transcription of the Il17 gene.
CNS2 Differentially Regulated IL-17 and IL-17F
Production in Different Types of Immune Cells In Vivo IL-17 and IL-17F can be expressed not only by Th17 cells but also by innate or innate-like immune cells, such as gd T and lymphoid tissue inducer (LTi) or LTi-like cells (Cua and Tato, 2010) . We first examined memory CD4 + T cells and found that CNS2 deficiency impacted IL-17 and IL-17F expression in a similar manner as in Th17 cells generated in vitro (Figures 5  and S4 ). Th17 cells are also abundant in gut-associated lymphoid tissues and are suggested to play an important role in mucosal immunity or immune homeostasis in the gut (Cua and Tato, 2010; Ivanov et al., 2006) . We therefore isolated laminal propria (LP) cells and intestinal intraepithelial lymphocytes (IELs) from the intestinal tissues of healthy WT and CNS2-deficient mice for intracellular staining analysis. To our surprise, CNS2 was required for optimal expression of IL-17 S4 ). In addition, we found that CNS2 was no longer required for IL-17F expression in both gd T and LTi-like cells and deletion of CNS2 even led to its increased expression (Figures 5 and S4 ). These results suggest that CNS2 differentially controls IL-17 and IL-17F expression in not only Th17 cells but also between adaptive and innate immune cells.
CNS2-Deficient Mice Were Resistant to Experimental Autoimmune Encephalomyelitis
To further understand the function of CNS2 during in vivo immune responses, we first examined the role of CNS2 in an allergic lung inflammation model by intranasally challenging mice with an allergenic fungal proteinase (FAP) derived from Aspergillus oryzae as described (Kiss et al., 2007; Yang et al., 2008a) . As expected, IL-17F expression was not impaired in lung tissues and lung gd T cells and was even increased in the absence of CNS2 ( Figures 6A, S5B , and S5C). Accordingly, we observed more neutrophils infiltrating the brondchoalveolar lavage (BAL) of CNS2-deficient mice ( Figure S5D ). To understand the role of CNS2 in Th17 cell generation in vivo, we immunized mice with MOG 35-55 peptide and found that the number and frequency of MOG-specific IL-17 + Th17 cells were greatly reduced in both the spleens and draining lymph nodes of CNS2-deficient mice ( Figure 6B ). To further test the contribution of CNS2 in the development of Th17 cell-dependent autoimmune diseases, both WT and CNS2-deficient mice were subjected to myelin oligodendrocyte glycoprotein (MOG) peptide-induced experimental autoimmune encephalomyelitis (EAE)-an autoimmune mouse disease model that closely resembles human multiple sclerosis (Baxter, 2007) . The severity of EAE diseases was significantly reduced in CNS2-deficient mice ( Figure 7A ). In our two independent EAE assays, only 1 of the 10 CNS2-deficient mice reached score 2. However, 9 of the 11 WT mice reached scores 2.5 or above. In addition, the disease onset was also delayed in CNS2-deficient mice (Figure 7A) . These results are consistent with the phenotype of EAE diseases in IL-17-deficient mice (Komiyama et al., 2006; Yang et al., 2008a) . Interestingly, two of the five diseased CNS2-deficient mice showed signs of recovery on day 9 after second immunization and one of them was fully recovered on day 10 (data not shown). However, none of the nine diseased WT mice showed any signs of recovery. The phenotype of early recovery from EAE was also observed in IL-17F-deficient mice (Komiyama et al., 2006; Yang et al., 2008a) . We then examined the expression of IL-17 and IL-17F in EAE mice. There was $3-fold reduction in the percentages of IL-17 + cells in the central nervous system and $2.3-fold reduction in the spleens of CNS2-deficient mice when compared with WT mice ( Figure 7B) . A dramatic reduction of IL-17 secretion was also observed by ELISA assays in the splenocytes of CNS2-deficient mice in EAE experiments ( Figure 7C ). Consistent with the in vitro differentiation results, IL-17F expression was also partially reduced as determined by ELISA assays ( Figure 7C ) or by intracellular staining in CNS2-deficient mice ( Figure S6 ). Interestingly, although the percentages of IFN-g + cells were not significantly The results were normalized to the input control and the overall change of chromatin accessibility was evaluated by using the ratio of histone markers H3Ac/H3K27me3. Shown here is one of three representative results. (C) Anti-p300 and anti-JMJD3 ChIP assays. The assay performed with anti-RNA Pol II, p300, or JMJD3 is shown as the combinational result from two to three independent experiments and the data from each replicate were normalized to the average IgG ChIP signals in WT and CNS2-deficient Th17 cells for comparison across biological replicates. All data shown as mean ± SD. See also Table S1 and Figure S3 .
Immunity
Requirement of CNS2 in Il17 Gene Transcription affected by the deletion of CNS2, the IL-17 + and IFN-g + doublepositive cells were completely absent in CNS2-deficient mice ( Figure 7B ). These data pinpoint the importance of CNS2 in regulating the expression of both IL-17 and IL-17F in vivo and Th17 cell-related autoimmune diseases.
DISCUSSION
In previous studies, we have identified a total of eight conserved noncoding sequences (CNS1-CNS8) located in the Il17-Il17f locus, which spread over 120 kb in the genome. Among these CNS sites, CNS2 is suggested to regulate IL-17 gene expression (Okamoto et al., 2010; Schraml et al., 2009; Yang et al., 2008b; Zhang et al., 2008) . However, the involvement of other CNS elements in regulating Th17 cell genes is also implicated. For example, CNS3-CNS5 all undergo hyperacetylation in Th17 cells and are shown to interact with Batf-a transcription factor that is crucial for Th17 cell differentiation (Schraml et al., 2009; Akimzhanov et al., 2007) . Moreover, there are more than six DNase I hypersensitivity sites located in the Il17-Il17f gene locus other than CNS2 in Th17 cells (Mukasa et al., 2010) . However, none of these cis elements have been examined in terms of their function in CD4 + T cells in vitro and in vivo. In this study, we characterized the function of a cis-acting element, CNS2. By using luciferase reporter gene assays in primary T cells, we demonstrate that CNS2 functions in a cell type-specific manner A total of six WT and five to six KO mice were analyzed in (B) and (C). All the data are shown as mean ± SD. See also Figure S6 .
in driving not only the Il17 but also the Il17f gene transcription. Moreover, CNS2 induced transcription in Th17 cells even when fused to Il4 or Ifng gene promoters, supporting the fact that CNS2 but not the Il17 and Il17f gene promoters dictates Th17 cell-specific transcription.
To examine the function of CNS2 in vivo, we generated CNS2-deficient mice and found that CNS2 controlled the expression of IL-17 in Th17 cells generated both in vitro and in vivo, as well as in memory CD4 + T cells. However, the expression of IL-17F was only partially dependent on CNS2, as shown by the fact that deficiency of CNS2 led to $45%-70% reduction of IL-17F expression in in-vitro-and in-vivo-generated Th17 cells. In contrast, in gd T and LTi-like cells, CNS2 mainly controlled the per-cell protein expression of IL-17 but not the frequency of IL-17 + population. The IL-17F expression, however, may be even increased in innate immune cells in CNS2-deficient mice. One exception to our findings is the Th17 (CD4 + IL-17 + ) cells present in the gut, which showed a similar CNS2-dependent regulatory pattern to innate immune cells in terms of IL-17 or IL-17F expression. These gut-resident Th17 cells are shown to constitutively express RORgt and readily produce IL-17 upon stimulation (Ivanov et al., 2006) and might represent a distinct Th17 cell population.
To understand the mechanism underlying the regulation of IL-17 and IL-17F by CNS2, we performed a 3C analysis and noticed that CNS2 can directly interact with the Il17 and Il17f gene promoters only in Th17 cells. The looping of both Il17 and Il17f genes together to CNS2 provides a physical basis for how these two genes are coordinately expressed in Th17 cells, whereas the lineage-specific looping suggests that this particular chromosomal configuration forms during Th17 cell differentiation and may involve lineage-specific transcription factors. This is in contrast to Th2 cells in which the Th2 LCR interacts with the cytokine gene promoters before the commitment of CD4 + T cells to Th2 cell lineage or even exists in other T cell lineages (Spilianakis and Flavell, 2004) . This difference may explain that fact that a basal level of IL-4, but not IL-17, is detectable in naive CD4 + T cells upon stimulation (Nakamura et al., 1997) . This study therefore provides a distinct looping mechanism for the function of trans-acting factors in regulating Th17 cell gene transcription. Chromatin remodeling in CD4 + T cells has been extensively studied because of its essential role in controlling helper T cell development and lineage plasticity. However, the involving cis-acting elements remain poorly understood in Th17 cells. Our study revealed an essential role of RORgt in mediating permissive histone remodeling of the Il17-Il17f gene locus in Th17 cells. RORgt critically controlled the permissive histone marker H3Ac at CNS2 and the Il17 promoter region in Th17 cells, as well as the repressive histone marker H3K27me3 and to a less extent at the Il17fp region. This result indicates an essential role of RORgt in the chromatin remodeling at CNS2. CNS2 then functions by controlling the chromatin structure at the Il17 or Il17f promoter region. Retroviral overexpression assays showed that CNS2 was indispensible for the function of RORs in mediating IL-17 expression. Taken together, these results suggest that the interaction between CNS2 and RORgt may play an important role in activation of the transcription at the Il17-Il17f gene locus.
Interestingly, we found that CNS2 was bound by histone remodeling enzymes p300 and JMJD3 in Th17 cells, which are shown to induce permissive acetylation of histone H3 or to remove the repressive histone marker H3K27me3, respectively (Agger et al., 2007; De Santa et al., 2007; Wang et al., 2008; Xiang et al., 2007) , suggesting that a histone remodeling enzymatic complex associates with CNS2 in Th17 cells, possibly by the interaction between CNS2 and RORgt. The looping of CNS2 with the promoters thus is able to bring CNS2-associated histone remodeling enzymes to the promoters for chromatin activation at distal regions.
In summary, this study provides a molecular basis of how cis-and trans-acting factors may function together in Th17 cells to drive selective cytokine gene expression. The commitment to Th17 cell lineage may begin by inducing one or more crucial early transcription factors, such as ROR factors, which bind to CNS2 and the Il17 and Il17f promoters to induce looping of the cytokine locus by interacting with each other or the basic transcriptional machinery assembled on the promoter regions. During this process, chromatin remodeling enzymes are recruited to CNS2 and possibly other cis elements and cause permissive and lineage-specific chromatin remodeling of the Th17 cytokine locus. The opening of the Il17-Il17f locus then leads to binding of more cell type-specific trans-acting factors, which interact with the basic transcriptional machinery because of close spatial proximity and then activate gene transcription in a robust and lineage-specific manner. Considering the importance of CNS2 in regulating IL-17 and IL-17F, characterization of the transcription factors and other cis elements that associate with CNS2 may reveal additional mechanisms underlying the differentiation of Th17 cells, a proinflammatory effector Th cell subset important in many inflammatory diseases.
EXPERIMENTAL PROCEDURES Primers
All the primers used for ChIP-PCR, mutagenesis, luciferase reporter, CNS2-targeting plasmid construction, and genotyping are listed in Table S1 . The real-time RT-PCR primers used to quantify Il17, Il17f, Il21, RORa, RORgt, and b-actin were described previously (Yang et al., 2008b) .
Mice
The CNS2-targeting plasmid was generated by cloning the sequences flanking the CNS2 site into pEASY-Flox vector that uses NeoR as positive and thymidine kinase as negative selection markers ( Figure S2A ). CNS2-deficient mice were generated by replacing the CNS2 fragment with a NeoR gene cassette flanked by Floxp sites via the 129/TC1 embryonic stem cell line (Figure S2A) . Targeted embryonic stem cell clones were selected and injected into C57BL/6 blastocysts to generate chimeras. High percentage chimeras were bred with C57BL/6 mice for germline transmission. The CNS2 +/À mice were obtained by crossing with the CMV-Cre strain to remove the NeoR cassette. The deletion of CNS2 alleles was detected by PCR (Figure S2B) . Homozygous WT and CNS2-deficient animals on the same 129 3 C57BL/6 F 1 mixed background were bred and used in experiments. All the mice were housed in the SPF animal facility at the M.D. Anderson Cancer Center and the animal experiments were performed at the age of 6-8 weeks with the use of protocols approved by the Institutional Animal Care and Use Committee.
Rorc À/À (RORg-deficient) mice were generated before (Kurebayashi et al., 2000) and their splenocytes were used for isolation of naive CD4 + T cells in this study.
Luciferase Reporter Assays
The Il17, Il17f, and Ifng promoters, without or together with CNS2, were cloned into PGL3 luciferase reporter plasmid. The ROR binding sites in CNS2 were mutated by site-directed mutagenesis. The PGL3-Il4p reporter construct was made before (Lee et al., 2001) .For all the reporter constructs, CNS2 was cloned into the MluI and XhoI sites and the promoters were cloned into XhoI and HindIII sites in PGL3 plasmid. All the primers used for cloning and mutagenesis were listed in Table S1 . Naive CD4 + T cells were isolated from C57BL/6 mice and differentiated under Th1 and Th17 cell conditions. On day 3, the cells were transfected with different luciferase reporter constructs together with a control Renilla luciferase reporter plasmid by using a Mouse T Cell Nucleofector Kit (LONZA, cat# VPA-1006) and Amaxa Nucleofector I (Amaxa Biosystem) according to manufacturer's instructions. The dualluciferase reporter system (Promega) was used to examine firefly and Renilla luciferase activity. Renilla luciferase was used to normalize transfection efficiency and luciferase activity.
Isolation of Different Immune Cells and T Cell Differentiation
For Th cell differentiation, naive T cells were isolated by sorting CD4
lo cells from spleens and lymph nodes, differentiated under several T helper cell conditions, and analyzed as described (Nurieva et al., 2007; Yang et al., 2008b) . Th0 cells (for retroviral infection): 0.5 mg ml
À1
anti-CD3 (plate-bound), 0.5 mg ml À1 anti-CD28 (soluble), 10 mg ml À1 anti-IL4 (11B11), 10 mg ml À1 anti-IFN-g (XMG), and 30 U ml À1 IL-2. Th1 cells: 1 mg ml
anti-CD3 (plate-bound), 1 mg ml À1 anti-CD28 (plate-bound), 10 mg ml À1 anti-IL4 (11B11), 10 ng ml À1 IL-12, and 30 U ml À1 IL-2. Th2 cells: 0.5 mg ml À1 anti-CD3
(plate-bound), 0.5 mg ml À1 anti-CD28 (soluble), 10 mg ml À1 anti-IFN-g, 10 ng ml À1 IL-4, and 30 U ml À1 IL-2. iTreg cells: 1 mg ml À1 anti-CD3 (platebound), 1 mg ml À1 anti-CD28 (plate-bound), 10 mg ml À1 anti-IL4 (11B11), 10 mg ml À1 anti-IFN-g, and 2.5 ng ml À1 TGF-b. lymph nodes, respectively, and analyzed by intracellular staining after phorbol 12-myristate 13-acetate (PMA) and ionomycin restimulation in the presence of Golgi-stop or by real-time RT-PCR after ex vivo restimulation. IELs and LP cells were isolated from the small intestine as previously described (Goodman and Lefranç ois, 1988; Laky et al., 1997) , and the cells was analyzed by intracellular staining after PMA and ionomycin restimulation in the presence of Golgi stop.
Chromosome Conformation Capture Assays
The chromosome conformation capture (3C) assays were performed as described with minor modifications (Tolhuis et al., 2002) . PstI and NsiI were used to generate restriction fragments of the Il17-Il17f locus in Th1 and Th17 cells. The ligation of CNS2 to the Il17 and Il17f promoters was detected by PCR amplification with primers shown in Table S1 . Undigested C57BL/6 genomic DNA was used as a negative control for the PCR reactions.
Retrovrial Transduction
RORa (GenBank accession XM_903197) and RORgt (GenBank accession AJ132394) were cloned into bicistronic retroviral vector pMIG-hCD2 containing IRES-regulated human CD2 as described (Nurieva et al., 2007; Yang et al., 2008b) . Naive CD4 + T cells were activated with 0.5 mg ml À1 anti-CD3
(plate-bound), 0.5 mg ml À1 anti-CD28 (soluble), and differentiated under Th0
and Th17 cell conditions. On day 1, the cells were infected by retroviruses RORa-hCD2, RORgt-hCD2, or control empty vector pMIG-hCD2. On day 4, the cells were restimulated with PMA and ionomycin in the presence of Golgi-stop for 5 hr, stained for surface marker hCD2 first, and then stained for IL-17 and IL-17F intracellularly.
ChIP-PCR Assays Cells were first cross-linked with 2% paraformadehyde for 10 min at 37 C and sonicated, and then the DNA-protein complexes were isolated with a ChIP assay kit (Millipore, Cat# 17-295) according to manufacturer's instructions with antibodies against p300 (SantaCruz), acetylated histone H3 (H3Ac) (Millipore), trimethylated histone H3-K27 (H3K27me3) (Millipore), RNA Polymerase II (SantaCruz), or JMJD3 (Abcam). The precipitated DNA was quantified by real-time PCR with primers listed in Table S1 . The results were normalized relative to the input control.
Quantitative Real-Time RT-PCR Total RNA was isolated from T cells with the use of Trizol reagent (Invitrogen) according to manufacturer's instructions. cDNAs were synthesized with Superscript reverse transcriptase and oligo(dT) primers (Invitrogen) and analyzed with an iCycler Optical System and an iQ SYBR green real-time PCR kit (Bio-Rad). The data were normalized to a b-actin control.
Allergic Lung Inflammation
Age-matched CNS2-deficient and their WT control mice were challenged intranasally twice with an allergenic fungal proteinase (FAP) derived from Aspergillus oryzae on day 1 at a dosage of 7 mg FAP and 43 mg OVA in 50 ml PBS per mice, and then we analyzed IL-17 and IL-17F expression in the lung tissues or lung gd T cells on day 2 as described (Kiss et al., 2007; Yang et al., 2008a) .
MOG Immunization and Induction of EAE
Both MOG immunization and EAE induction were performed by immunizing mice with 300 mg MOG 35-55 peptide (amino acids 35-55; MEVGWYRSPFS ROVHLYRNGK) emulsified in CFA and analyzed as previously described (Nurieva et al., 2007; Yang et al., 2008b) . The disease scores were assigned on a scale of 0-5 as follows: 0, none; 1, limp tail or waddling gait with tail tonicity; 2, wobbly gait; 3, hindlimb paralysis; 4, hindlimb and forelimb paralysis; 5, death.
Calculations and Statistic Analysis
All our in vitro data were repeated at least 2-5 times with consistent results. When indicated, the statistical significance was determined by Student's t test (*p < 0.05; **p < 0.03; ***p < 0.01).
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